Many widely repeated statements about drug use are flat-out wrong. Some of the most persistent myths include “addiction is a choice,” “you have to hit rock bottom before getting help,” “marijuana isn’t addictive,” and “prescription drugs are safe because a doctor prescribed them.” These false beliefs shape how people think about substance use, delay treatment, and sometimes cost lives. Here are the most common myths, what the evidence actually shows, and why the distinction matters.
“Addiction Is Just a Choice”
The first use of a substance may involve a voluntary decision, but addiction itself is not a matter of willpower. Repeated drug use physically rewires brain circuitry in ways that make compulsive use increasingly difficult to resist. The brain’s reward center, a cluster of structures called the basal ganglia, responds to drugs by flooding the system with dopamine. Over time, this process shifts from the region responsible for pleasure to the region responsible for habits, essentially converting a reward-seeking behavior into an automatic one. That transition is driven by measurable changes in how brain cells communicate, not by a character flaw.
Addiction also disrupts the prefrontal cortex, the part of the brain responsible for decision-making, impulse control, and weighing consequences. As this area loses influence, a person’s ability to “just stop” genuinely diminishes. A third set of changes occurs in brain regions tied to stress and negative emotions, creating intense discomfort during withdrawal that powerfully drives continued use. These three overlapping cycles, reward, stress, and impaired self-control, are why the medical community classifies addiction as a chronic brain disorder rather than a moral failing.
“You Have to Hit Rock Bottom First”
This is one of the most dangerous myths in substance use because it encourages people to wait. The U.S. Surgeon General’s office is clear on this point: the most effective way to help someone at risk for a substance use disorder is to intervene early, before the condition progresses. Mild substance use problems can be identified quickly in many medical and social settings, and they often respond well to brief motivational counseling or guided self-change programs.
Waiting for a crisis actually makes recovery harder. Severe, complex, and chronic substance use disorders require more intensive specialty treatment and longer post-treatment support. Meanwhile, a common feature of substance use disorders is that people tend to underestimate how serious their problem has become and overestimate their ability to control it. That combination means someone who appears to be “not bad enough yet” from the outside may already be in real trouble. Earlier treatment leads to better outcomes, period.
“Marijuana Isn’t Addictive”
Cannabis can and does produce dependence. According to the CDC, roughly 3 in 10 people who use cannabis develop cannabis use disorder, a condition characterized by difficulty stopping use despite negative effects on health, relationships, or daily responsibilities. That 30% likelihood makes cannabis significantly more habit-forming than many people assume.
Cannabis withdrawal is real, too. Regular users who stop often experience irritability, sleep disruption, decreased appetite, and cravings that can last one to two weeks. The potency of cannabis products has also increased dramatically over the past two decades, which may be raising the risk of dependence for newer users. None of this means that everyone who uses cannabis will develop a problem, but the claim that it “isn’t addictive” is simply false.
“Prescription Drugs Are Safe Because a Doctor Prescribed Them”
Prescription opioids fueled the first wave of the overdose crisis in the United States, and they continue to contribute to tens of thousands of deaths each year. A doctor’s prescription does not eliminate the risk of dependence, misuse, or overdose. Opioid painkillers act on the same brain receptors as heroin, and the transition from prescribed use to problematic use is well documented.
While the rate of overdose deaths involving prescription opioids has been declining (dropping nearly 12% between 2022 and 2023), that decrease is partly because the crisis shifted to illegally manufactured fentanyl. The underlying lesson stands: prescribed does not mean harmless. Sedatives, stimulants, and anti-anxiety medications also carry real risks of dependence when used outside their intended guidelines, or sometimes even within them.
“Addiction Is All About Willpower, Not Genetics”
Genetics account for 40% to 60% of a person’s vulnerability to addiction, based on a large meta-analysis of twin studies. That’s a substantial chunk of risk that has nothing to do with personal discipline. The genetic influence also shifts with age. At 14, genes explain only about 18% of the variation in drinking behavior, while shared environment (family, peers, neighborhood) accounts for over 70%. By 18, those numbers essentially flip: genetics explain about half the variation, while shared environment drops to roughly 15%.
This doesn’t mean addiction is purely genetic, either. Environmental factors like trauma, stress, peer influence, and drug availability all play significant roles, especially in adolescence. The point is that reducing addiction to a matter of willpower ignores the biology that makes some people far more vulnerable than others from the start.
“Relapse Means Treatment Failed”
Relapse rates for substance use disorders fall between 40% and 60%. That sounds discouraging until you compare it to other chronic conditions: the relapse rates for high blood pressure and asthma are in the same range. Nobody claims that a person with asthma who has a flare-up has “failed” treatment. The same logic applies to addiction.
Relapse is often a signal that treatment needs to be adjusted, resumed, or changed, not abandoned. Medication-based treatment for opioid use disorder, for example, has strong evidence behind it. One study of more than 17,500 opioid overdose survivors found that two common treatment medications reduced opioid-related deaths by 38% to 59% compared to no medication. Yet only about 10% of people diagnosed with opioid use disorder received medication-based treatment in the year following their diagnosis. The gap between what works and what people actually receive is enormous, driven partly by the false belief that relapse equals failure.
“Teens Can Experiment Without Real Consequences”
The adolescent brain is not a smaller version of an adult brain. It is still under construction, with the prefrontal cortex (responsible for judgment and impulse control) not fully maturing until the mid-20s. Substance use during this window causes disproportionate harm. Heavy alcohol use in adolescence damages the hippocampus, a brain structure critical for memory, and heavy drinkers perform measurably worse on cognitive tasks even at age 24 compared to peers who drank lightly.
Cannabis use during adolescence also leaves marks. Studies show that marijuana-using teens have altered brain structure, with changes in gray matter volume that correlate with poorer verbal ability and weaker attention. These cognitive deficits have real downstream effects on academic performance, career outcomes, and social functioning that can extend well into adulthood. Experimentation at 15 carries fundamentally different biological risks than use at 25.
“Touching Fentanyl Can Cause an Overdose”
This claim spread widely through alarming news reports and viral videos showing first responders allegedly collapsing after brushing against fentanyl powder. Toxicologists have thoroughly debunked it. The American College of Medical Toxicology and the American Academy of Clinical Toxicology released a joint statement clarifying that fentanyl toxicity from brief skin contact is so unlikely as to be nearly impossible. Fentanyl does not absorb through the skin fast enough to cause a rapid overdose. Medical fentanyl patches, which are specifically designed for skin absorption, take hours to deliver a therapeutic dose even with sustained contact.
The reported incidents among first responders are consistent with panic attacks and anxiety responses, not opioid toxicity. This myth matters because it discourages bystanders from helping during actual overdoses and fuels unnecessary fear among people who might otherwise administer life-saving care.